Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Antibe Therapeutics Inc (ATBPF)

Antibe Therapeutics Inc (ATBPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, today announced...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics Reports Q3 2022 Interim Financial and Operating Results

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, has filed its financial...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics Reports Q2 2022 Interim Financial and Operating Results

Antibe Therapeutics Inc. (TSX:ATE, OTCQX:ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, has filed its financial and...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics Outlines Plan for Otenaproxesul's Acute Pain Program

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions,...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics Provides Update on Otenaproxesul and Expanded Drug Pipeline

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions,...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions,...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics Announces Results of 2021 Annual Meeting

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, is pleased to announce...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics Reports Q1 2022 Interim Financial and Operating Results

Antibe Therapeutics Inc. (TSX:ATE, OTCQX:ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, has filed its financial and...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)
Antibe Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions,...

ATE.TO : 0.69 (unch)
ATBPF : 0.5500 (+3.83%)

Barchart Exclusives

3 Bearish Option Trade Ideas For This Friday
If the bearish stock market has got you down, maybe it’s time to start looking at option trades rather than boring old buy and hold. Today, we’re going to look at how to find bearish options trade ideas using the Bear Put Spread Screener. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar